Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation.
Journal
HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
14
03
2023
accepted:
23
05
2023
medline:
5
7
2023
pubmed:
5
7
2023
entrez:
5
7
2023
Statut:
epublish
Résumé
Hematopoietic cell transplantation (HCT) is a curative approach for myelofibrosis patients, but relapse is a major cause of treatment failure. We investigated the effect of donor lymphocyte infusion (DLI) in 37 patients with molecular (n = 17) or hematological relapse (n = 20) after HCT. Patients received median of 2 (range, 1-5) cumulative DLI (total of 91 infusions). Median starting dose was 1 × 10
Identifiants
pubmed: 37404772
doi: 10.1097/HS9.0000000000000921
pmc: PMC10317484
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e921Informations de copyright
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Bone Marrow Transplant. 2022 Mar;57(3):510-512
pubmed: 35046544
Br J Haematol. 2018 Aug;182(3):418-422
pubmed: 29808926
Biol Blood Marrow Transplant. 2019 Jun;25(6):e204-e208
pubmed: 30930192
Bone Marrow Transplant. 2017 Nov;52(11):1526-1529
pubmed: 28714945
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Blood. 2010 Nov 4;116(18):3572-81
pubmed: 20489052
Hemasphere. 2022 Sep 30;6(10):e784
pubmed: 36204690
Blood. 2019 May 16;133(20):2233-2242
pubmed: 30760453
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
J Clin Oncol. 2011 Feb 20;29(6):761-70
pubmed: 21205761
Biol Blood Marrow Transplant. 2007 Mar;13(3):355-65
pubmed: 17317589
Bone Marrow Transplant. 2003 Apr;31(8):687-93
pubmed: 12692609
Blood. 2019 May 16;133(20):2118-2120
pubmed: 31097535
Blood. 2006 Sep 1;108(5):1497-503
pubmed: 16675707
Cancers (Basel). 2020 Oct 23;12(11):
pubmed: 33114179
Br J Haematol. 2012 Oct;159(2):172-81
pubmed: 22909192
Leukemia. 2021 Sep;35(9):2445-2459
pubmed: 34040148
Haematologica. 2023 Jul 01;108(7):1900-1908
pubmed: 36779595
Br J Haematol. 2000 Feb;108(2):430-3
pubmed: 10691877
Bone Marrow Transplant. 2021 Sep;56(9):2160-2172
pubmed: 33911203
Blood. 2009 Feb 19;113(8):1866-8
pubmed: 19228938
Blood. 2001 Sep 15;98(6):1695-700
pubmed: 11535499
Front Immunol. 2017 Jun 07;8:496
pubmed: 28638379
Leukemia. 2015 Nov;29(11):2126-33
pubmed: 26293647
Eur J Haematol. 2019 Dec;103(6):552-557
pubmed: 31446640
Blood. 2009 Dec 17;114(26):5264-70
pubmed: 19812383
Am J Hematol. 2021 Jan;96(1):145-162
pubmed: 33197049
Leukemia. 2007 May;21(5):943-8
pubmed: 17361226
Haematologica. 2019 Jun;104(6):1230-1236
pubmed: 30655365
Biol Blood Marrow Transplant. 2017 Jul;23(7):1095-1101
pubmed: 28389256